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Abstract  Catheter  ablation  of  arrhythmogenic  triggers  has  been  validated  for  the  treatment
of atrial  ﬁbrillation  that  is  refractory  to  anti-arrhythmic  medication.  Imaging  plays  an  important
role in  guiding  the  procedure  as  well  as  in  planning  and  follow-up.  The  goal  of  pre-procedural
imaging is  to  obtain  a  detailed  anatomical  description  of  the  pulmonary  veins,  to  eliminate  a
thrombus  of  the  left  atrium  and  to  deﬁne  the  prognostic  factors.  MDCT  angiography  effectively
and simply  meets  nearly  all  of  these  needs.  Thus,  a  precise  description  of  the  left  atrium
anatomy before  the  procedure  is  a  key  factor  to  success  and  left  atrium  volume  is  a  reliable
prognostic  factor  of  recurrence.  Radiologists  should  be  aware  of  early  and  late  complications,
sometimes  severe  such  as  pulmonary  vein  stenosis,  cardiac  tamponade  or  atrial-esophageal
ﬁstula, whose  positive  diagnosis  is  based  on  imaging.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Since  the  1990s  and  the  preliminary  study  of  Haïssaguerre  et  al.  [1], catheter  ablation
of  left  atrial  arrhythmogenic  triggers  has  become  a  valid  option  for  the  treatment  of
atrial  ﬁbrillation  (AF)  that  is  refractory  to  classic  antiarrhythmic  medications.  Besides
peri-procedural  guidance,  imaging  also  plays  a  essential  role  in  planning  and  follow-up
[2].
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The  goals  of  this  review  are  to  describe  the  physiolog-
cal  bases  of  AF  and  the  methods  of  catheter  ablation,  to
eﬁne  imaging  acquisition  and  post-treatment  protocols  for
ultidetector  computed  tomography  (MDCT)  angiography
f  the  pulmonary  veins,  to  identify  the  morphological  and
rognostic  information  that  should  be  obtained  to  plan  the
rocedure  and  to  deﬁne  post-therapeutic  follow-up  imaging
odalities.
atheter ablation of atrial ﬁbrillation
hysiopathology of atrial ﬁbrillation
F  is  the  most  frequent  heart  rhythm  disorder,  affecting  5%
f  patients  over  the  age  of  65  and  up  to  10%  over  the  age  of
0  years  [3].  The  clinical  symptoms  of  this  supraventricular
achycardia  characterized  by  chaotic  atrial  activity  are  dys-
nea,  palpitations,  and  more  rarely  loss  of  consciousness.
t  may  also  be  revealed  by  an  initial  complication  (stroke,
eart  failure).  The  positive  diagnosis  is  made  by  electro-
ardiogram  (ECG),  which  shows  an  irregular  rhythm  with
o  visible  P  waves,  replaced  by  an  irregular  baseline  wave,
hich  is  a  sign  of  chaotic  electric  atrial  activity  (Fig.  1).
There  are  four  types  of  AF  depending  on  the  duration  of
he  episode  [4,5].  They  include:
paroxysmal  AF,  which  generally  lasts  less  than  48  hours,
and  always  less  than  seven  days;
persistent  AF,  which  lasts  more  than  seven  days  or  requires
pharmacological  cardioversion;
longstanding  persistent  AF,  which  lasts  more  than  a  year;
permanent  AF,  which  is  accepted  by  the  cardiologist  and
for  which  no  cardioversion  is  considered  [6].
The  physiopathology  of  AF  is  complex  and  requires  a  trig-
er  as  well  as  a  substrate  to  become  chronic  [7].  Triggers
re  arrhythmogenic  zones  that  are  mainly  found  around  the
stia  of  the  pulmonary  veins  (PV),  but  that  may  also  be
ound  around  the  superior  vena  cava  or  the  coronary  sinus.
F  results  in  electric  and  structural  endomyocardial  remod-
ling  (alterations  of  the  extracellular  matrix  and  myocytes)
eading  to  a  myoﬁbroblastic  proliferation  with  ﬁbrosis,  caus-
ng  zones  of  slow  conduction  and  atrial  electric  conduction
isturbances.  This  remodeling  and  ﬁbrosis  result  in  re-entry
ircuits  [8]  and  chronic  AF.  The  pathophysiology  of  persistent
nd  permanent  AF  seems  to  be  even  more  complex,  involving
igure 1. Schematic ECG in a patient with regular sinusoidal
hythm (a) and in a patient with atrial ﬁbrillation (b), with irregular
scillation of the baseline and absence of P waves.
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ardiac  innervation  [9]  as  well  as  certain  anatomical  struc-
ures  such  as  the  ligament  of  Marshall  [10]  or  the  rotors
11—13],  which  are  electric  ‘‘wavelets’’  that  are  propagated
n  certain  atrial  regions.
Destruction  of  these  electric  or  anatomical  abnormalities
y  isolation  of  the  PV  and  ablation  of  the  left  atrial  sub-
trate  can  eliminate  arrhythmia  and  is  the  basis  of  curative
blation  techniques  [14].
rinciples of catheter ablation
here  are  two  main  indications  for  technical  ablation  of  AF.
ne  is  symptomatic  paroxysmal  AF  that  does  not  respond  to
ptimal  anti-arrhythmic  medication  (grade  Ia),  or  prior  to
he  initiation  of  an  antiarrhythmic  drug  in  voluntary  patients
grade  IIa).  The  other  is  symptomatic  persistent  AF  refrac-
ory  or  intolerant  to  medical  treatment  (grade  IIa)  [4,5,7].
oals of catheter ablation
he  goal  of  catheter  ablation  of  AF  is  twofold  [7].  First,
o  obtain  circumferential  isolation  of  the  PV  (ostium  and
ntrum)  to  electrically  isolate  the  focal  triggers  initiating
he  AF.  This  ﬁrst  step  is  essential  and  is  often  sufﬁcient
n  paroxysmal  AF.  Second,  to  obtain  a  fragmentation  and
ompartmentalization  of  the  left  atrium  (LA).  This  non-
tandardized  step  is  usually  required  in  persistent  AF.  Linear
efragmentation  involves  radiofrequency  thermoablation  of
o-called  fragmented  zones  exhibiting  Complex  Fraction-
ted  Atrial  Electrograms  (CFAE)  or  rotors  [12,13,15].  The
reation  of  linear  lesions  within  the  LA  (roof,  mitral  isth-
us)  resulting  in  a  compartmentalization  could  help  prevent
he  propagation  of  these  rotors,  which  participate  in  the
evelopment  of  chronic  AF.
If  they  are  correctly  performed,  these  procedures  have
n  excellent  short-term  success  rate  of  between  75  and  90%
7,16]  with,  however,  retreatment  necessary  in  more  than
5%.  The  long-term  efﬁcacy  is  still  a  subject  of  debate  due
o  possible  late  recurrence.  The  best  results  are  obtained  in
aroxysmal  AF  [17].
escription of the procedure
he  procedure  is  performed  in  an  interventional  cardiology
oom,  under  ﬂuoroscopic  guidance  with  optional  trans-
sophageal  echocardiographic  control  [18].  The  procedure
an  be  performed  under  general  or  local  anesthesia  depend-
ng  on  the  usual  practices  of  the  medical  team.  These  are
omplex  procedures  that  last  two  to  ﬁve  hours.
The  ﬁrst  step  involves  guiding  the  different  catheters
ith  vascular  access  through  the  right  femoral  vein  via  the
nferior  vena  cava  into  the  right  atrium,  then  into  the  LA
fter  transseptal  puncture.  The  operator  positions  the  dif-
erent  catheters  (lasso  and  ablation)  in  the  LA  as  well  as  a
atheter  in  the  coronary  sinus.  An  esophageal  temperature
robe  can  be  used  in  sedated  patients  to  mark  the  position
nd  indicate  the  temperature.
The  second  step  is  the  3D  mapping  of  the  LA  using  the  cir-
umferential  lasso  (Fig.  2a),  whose  position  is  determined
y  the  navigation  system  on  real  time.  Through  repetitive
ontact,  it  reconstructs  the  walls  of  the  LA  in  a  3D  model.
n  the  most  recent  workstations  equipped  with  mapping
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Figure 2. Lasso catheter used for LA mapping (a). By repeated contacts, it reconstructs the walls of the LA in twenty minutes (b), obtaining
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systems,  this  model  is  merged  and  synchronized  with  pre-
operative  imaging  data  (Fig.  2b  and  c).  The  lasso  catheter
can  also  be  used  to  gather  data  on  electrical  activity  within
the  LA  with  integrated  electrodes  (Fig.  2d)  [14].
The  third  step  is  the  ablation  procedure  itself,  usually  by
radiofrequency  (RF)  under  direct  real-time  guidance  of  the
RF  ablation  catheter  on  merged  images.  It  is  also  possible  to
use  a  cryoablation  balloon  procedure  to  isolate  the  PV  [19].
Cryoablated  lesions  result  in  less  marked  disorganization  of
underlying  myocardial  structures  and  less  thrombogenicity.
Thus,  the  risk  of  cryoablation  is  potentially  lower,  however
its  long-term  efﬁcacy  may  also  be  lower  [20],  although  this
must  be  conﬁrmed  in  an  ongoing  evaluation  of  the  most
recent  balloons.  At  present,  cryoablation  is  recommended
for  the  isolation  of  PV  in  paroxysmal  AF.  The  choice  between
cryoablation  and  RF  is  therefore  based  on  the  type  of  AF
as  well  as  the  usual  practices  and  local  possibilities  of  the
center.
The  operator  ﬁrst  isolates  the  PV  by  widely  encircling
the  outer  rim  of  the  ostia  in  the  left  then  right  PV,  and
sometimes  performs  intervenous  isolation  (Fig.  3a  and  b)
[14].  Performing  ablation  at  a  distance  from  the  PV  ostia,  in
the  antrum,  limits  the  risk  of  pulmonary  vein  stenosis.  The
operator  then  continues  ablation  of  the  zones  of  fragmented
activity  within  the  LA:  the  creation  of  linear  lesions  can  be
considered  between  the  superior  PV  (roof  line)  or  between
t
(
se tip of the lasso catheter has multiple oriﬁces (d, red circles) to
he  inferior  left  PV  and  the  mitral  annulus  (left  isthmic  line)
Fig.  3c  and  d).
natomy of the pulmonary veins
eventy-percent  of  patients  followed  for  AF  have  a  normal
V  anatomy  with  two  right  PV  and  two  left  PV,  one  inferior
nd  one  superior  on  each  side  [21].
Anatomical  variations  include:
a  common  ostium,  deﬁned  by  the  common  draining  of
the  inferior  and  superior  PV  directly  into  the  LA  with  no
intervenous  segment;
an accessory  PV,  corresponding  to  a  supernumerary  PV
with  a  separate  ostium;
late  fusion,  when  the  merging  of  the  venous  segments
occurs  less  than  5  mm  before  the  ostium  (Fig.  4).
natomical variants of the right PV
n  80%  of  patients,  the  anatomy  of  the  right  PV  is  normal
ith  two  ostia.  The  right  ostium  is  generally  rounder  and
ider  than  the  left.  The  ostium  of  the  superior  PV  is  larger
han  the  one  of  the  inferior  PV.
In  15%  of  patients,  there  is  a  supernumerary  middle  PV
Fig.  5) [22]. The  middle  PV  drains  directly  into  the  right
uperior  PV  in  80%  of  patients,  into  the  right  inferior  PV  in
1116  M.  Ohana  et  al.
Figure 3. RF ablation of arrythmogenic zones: the operator begins with the PV ostia (schema of RF points on an endoluminal view — a),
each treated point is reproduced on the navigation system (ﬁnal view after isolation of the 4 PV — b). As ﬁrst line treatment for permanent
AF, the procedure is completed with ablation of the rooﬂine of the LA (c) and the left isthmic line (d).
Figure 4. Example of early division of the middle PV (a, arrow), which drains into the right superior VP less than 5 mm before the ostium.
The endoluminal view (b) identiﬁes the ostium of the superior right PV (light blue dotted line), the middle PV (continuous red line) and the
inferior right PV (thin blue dotted line), at a distance from the ﬁrst two.
Figure 5. A 62-year-old man with paroxysmal AF. 3D view (a) showing middle PV with clear separate ostium (yellow arrow). Endoluminal
view (b) conﬁrming the presence of 3 distinct ostia (violet arrows).
Imaging  of  AF  ablation  1117
Figure 6. A 82-year-old man with persistent AF. 3D views (a and b) showing a middle PV with a clearly separate ostium (yellow arrow)
row).
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left  PV  are  rare  and  are  only  found  in  less  than  1%  of  patients.
This  is  nearly  always  a  PV  of  lingular  origin  (Fig.  10).and an thin accessory PV of the apical right inferior lobe (purple ar
5%  of  patients  and  ﬁnally  into  the  ostium  itself  in  15%  of  the
cases,  which  creates  a  supernumerary  PV.
Other  supernumerary  right  PV  are  rare  and  are  only  found
in  5%  of  the  cases.  These  accessory  PV  are  nearly  always  thin
(Fig.  6).  They  are  named  according  to  the  pulmonary  seg-
ment  they  originate  from.  They  are  double  in  less  than  0.5%
of  patients.  The  presence  of  a  single  common  right  ostium  is
rare  and  is  found  in  less  than  0.5%  of  patients.  Finally,  and  in
extremely  rare  cases,  a  supernumerary  left  atrial  appendage
(LAA)  may  be  found  (Fig.  7),  generally  located  near  the  right
PV.
Anatomical variants of the left PV
In  90%  of  patients,  the  anatomy  of  the  left  PV  is  normal  with
two  ostia.  Some  authors  consider  that  there  is  a  common
segment  (short  or  long)  between  the  inferior  and  superior  PV
Figure 7. A 67-year-old man with persistent AF. 3D view showing
an accessory LAA (arrow).
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‘n  80%  of  the  cases,  so  that  they  speak  of  a  common  ostium
n  the  vast  majority  of  the  patients  (Fig.  8)  [2].  Practically
peaking,  this  is  a question  of  semantics  with  no  clinical  con-
equences,  and  it  is  better  to  continue  to  describe  these
ases  as  a  normal  anatomy  with  two  separate  ostia.  A  com-
on  left  ostium  is  found  in  10%  of  patients  (Fig.  9).  Accessoryigure 8. A 56-year-old woman with persistent AF. 3D view show-
ng two left PV (a). Depending on where the ostium is deﬁned,
ertain authors speak of a common ostium with a common long
egment (b). We  can consider that there are two ostia, since the
‘common segment’’ can be viewed as the LA.
1118  M.  Ohana  et  al.
Figure 9. A 64-year-old man with persistent AF. 3D view (a) showing a common left ostium (yellow arrow) and endoluminal view (b)
conﬁrming the single left ostium (purple dotted line) and two right ostia (green dotted line).
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ligure 10. A 51-year-old man with paroxysmal AF. 3D view (a)
isualized on curvilinear multiplanar reconstruction (b). Endolumin
re-procedural imaging
oals and  importance
igh  quality  pre-procedural  imaging  has  three  main  goals.
irst,  to  gain  a  comprehensive  understanding  of  the  PV
natomy  to  identify  any  technical  difﬁculties  (in  particular
n  case  of  a  common  ostium),  to  make  sure  that  all  supernu-
erary  PV  are  isolated  (potential  cause  of  recurrence),  and
o  reduce  the  procedure  time.  Second,  to  detect  any  poten-
ial  risks  [23]:  pre-existing  stenosis  of  the  PV  in  patients
ho  have  already  been  treated,  atypical  position  of  the
sophagus  and  thrombus  in  the  LA  or  LAA,  which  is  found
n  approximately  2%  of  patients  (Fig.  11).  Third,  to  have
eference  images  should  complications  occur.
MDCT  angiography  of  the  PV  is  the  gold  standard
nd  can  easily  and  successfully  meet  nearly  all  of  these
equirements.  MR  angiography  is  an  alternative  that  can
t
s
e
eing a very thin left accessory PV (yellow arrow), that is clearly
w (c) conﬁrming the small distinct ostium (c — green arrow).
e  proposed  as  a  second  line  pre-procedural  technique.
ccording  to  guidelines,  pre-therapeutic  transesophageal
chocardiography  must  also  be  performed  to  detect  throm-
us  of  the  LA  or  LAA,  which  is  a  contraindication  to  catheter
blation.
DCT of the pulmonary veins
 protocol  is  suggested  in  Table  1. The  success  of  this  exam-
nation  depends  on  optimal  contrast  agent  injection  and
riggering  of  the  acquisition.  In  our  experience,  the  quality
f  the  images  is  suboptimal  in  less  than  2%  of  the  cases.
Certain  authors  [24]  recommend  an  additional  low  dose
ate-phase  acquired  30  s  later,  centered  on  the  cardiac  mass
o  identify  LA  or  LAA  thrombus  and  differentiate  it  from
imple  ﬂow  artifacts.  This  could  raise  the  sensitivity  and
specially  the  speciﬁcity  upt  to  those  of  transesophageal
chocardiography.  A  dual  energy  [25]  acquisition  could
Imaging  of  AF  ablation  1119
Figure 11. Axial slices of MDCT angiography of the pulmonary vein before AF ablation: thrombus in the LA and LAA in a 77-year-old
patient with persistent AF (a), conﬁrmed on TTE. Incomplete opaciﬁcation of the LAA in a 36-year-old patient with paroxysmal AF (b), with
a normal TEE: simple ﬂow artifact.
Table  1 Acquisition  protocol  for  64-row  MDCT  angiog-
raphy  of  the  pulmonary  veins  without  ECG-gating.
Field  of  view  From  the  aortic  arch  to  2  cm  below
the  cardiac  apex
Constants  100  kV
Automatic  tube  current  modulation
Noise  index:  38
Collimation:  64  mm  ×  0.625  mm
Rotation  time:  0.4  s
Pitch:  1
Injection  High  concentration  Iodine  contrast
media  (350—400  mg/mL,  70  mL)
Automatic  bi-phasic  injection:
50  mL  at  5  mL/s  then  20  mL  at
2.5  mL/s  followed  by  30  mL  of
saline  ﬂush  at  3  mL/s
Acquisition  Automatic  bolus-tracking:  ROI  in
the  ascending  aorta  and  a  trigger
threshold  of  160  HU
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There  are  two  possible  sequences  for  these  examinationsprovide  the  same  results  in  one  pass  [26].  Using  the  standard
protocol  proposed  in  Table  1,  LA  and  LAA  enhancement
was  insufﬁcient  in  less  than  5%  of  cases,  and  we  feel  that
although  these  more  advanced  techniques  are  interesting,
there  is  not  enough  clinical  beneﬁt  to  justify  the  increased
radiation  exposure  or  the  complexity  of  obtaining  additional
acquisitions.
The  theoretical  beneﬁts  of  ECG-gated  MDCT  angiography
[21]  include  suppression  of  the  cardiac  motion  artifacts,  and
the  possibility  of  analyzing  the  valves  and  the  proximal  por-
tions  of  the  coronary  arteries,  which  could  theoretically  be
useful  in  this  potentially  high-risk  population.  In  practice,  it
is  more  complicated  to  perform,  increases  the  acquisition
times,  does  not  improve  the  quality  of  3D  reconstruct-
ions,  signiﬁcantly  increases  radiation  exposure  (on  a  64-row
scanner)  and  does  not  always  provide  useful  additional  infor-
mation  in  patients  with  known  heart  disease  who  have  often
already  undergone  coronary  tests.  Thus,  and  unless  high  per-
formance  equipment  (320-row  or  dual  source  scanners)  that
can  provide  prospective,  low  radiation  synchronized  acqui-
sitions  is  available,  we  do  not  feel  that  the  use  of  this
technique  is  justiﬁed.  In  our  experience,  mean  radiation
(
cigure 12. A 77-year old man  with permanent AF. 3D segmenta-
ion of the LA showing abnormally increased LA volume of 196 mL.
xposure  with  a 64-section  MDCT  is  270  ±  80  mGy.cm  (i.  e.,
pproximately  5mSv).
The  report  should  mention  the  anatomy  of  the  PV  includ-
ng  the  number  and  position  of  any  supernumerary  veins;  as
ell  as  the  absence  of  stenosis  of  the  ostia.  Filling  of  the  LA
nd  LAA  should  also  be  reported  [23]: indeed,  CT  is  highly
ensitive  (nearly  100%)  for  detecting  LAA  thrombus,  but  with
umerous  false  positives  (PPV  of  only  23%)  (Fig.  11).  Thus,
ertain  authors  suggest  that  pre-procedural  TEE  should  not
e  performed  in  low  risk  patients  (<75  years  old,  without
evere  heart  failure,  severe  hypertension,  or  diabetes)  in
he  absence  of  any  images  suggesting  thrombus  on  MDCT
27].
Determination  of  LA  volume  (Fig.  12),  with  and  without
he  LAA,  should  also  be  reported.  Measurement  by  MDCT
xpressed  in  mL  is  more  precise  than  by  ultrasound,  which
as  a  tendency  to  underestimate  results  [28,29].  Normal  val-
es  on  echocardiography  are  below  22  ±  6  mL/m2,  or  less
han  53  mL  in  an  adult  male.  Dilatation  is  considered  to  be
resent  above  40  mL/m2, or  at  approximately  75  mL  in  an
dult  male  patient  [30].
The  position  of  the  esophagus  in  relation  to  PV  ostia  must
lso  be  determined,  even  if  this  may  vary  once  the  patient  is
nesthetized.  It  is  usually  located  near  the  ostium  of  the  left
nferior  PV.  Finally,  any  possible  mediastinal  or  parenchy-
atous  anomalies  in  the  area  being  explored  should  also  be
eported  [31,32].
3D  volume  rendering  reconstructions  of  the  LA  with  seg-
entation  of  the  initial  portions  of  the  PV  provide  realistic
D  images  that  are  useful  for  the  interventional  cardiologist.
R angiography of the pulmonary veinsFig.  13).  One  is  an  ECG-gated  contiguous  gradient-echo
ine  sequence  (such  as  B-TFE).  The  other  is  an  ultrarapid
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cho sequence (b).
radient-echo  3D  contrast-enhanced  T1  sequences  (such  as
HRIVE/VIBE)  without  ECG-gating.
Although  it  has  the  advantage  of  not  exposing  patients
ho  will  receive  high  doses  of  peri-procedural  radiation  to
urther  radiation,  does  not  require  iodinated  contrast  media
nd  provides  better  contrast,  the  spatial  resolution  and  the
uality  of  the  3D  reconstructions  is  slightly  poorer  with  MR
ngiography  than  with  MDCT  angiography.  Moreover,  this
quipment  is  not  easily  available  in  all  centers.  Neverthe-
ess,  it  is  used  as  the  ﬁrst  line  technique  by  certain  teams
33]  with  excellent  results  (99%  of  diagnostic  scans  and  90%
f  very  good  quality  scans).  Moreover  3D  post-gadolinium
ontrast-enhanced  sequences  seem  to  be  highly  sensitive
nd  speciﬁc  for  diagnosing  LA  or  LAA  thrombus,  with  results
hat  are  equivalent  to  transesophageal  echocardiography
34].
i
a
w
r
igure 14. Morphological variants of the left ventricle: ‘‘chicken wing
c), with a four times greater risk, and ‘‘cauliﬂower’’ (d) with a risk of se sequence (a) and T-1 weighted gadolinium enhanced 3D gradient
rognostic factors
he  volume  of  the  LA  is  the  only  validated  imaging  progno-
tic  factor.  An  increase  in  the  volume  of  the  LA  correlates
ith  higher  post-procedural  recurrence  of  AF.  In  case  of
ersistent  AF,  a  volume  >  130—145  mL  is  a  marker  of  recur-
ence  [30,35];  the  threshold  could  even  be  95  mL  in  case  of
aroxysmal  AF  [36].  Altogether,  a  LA  volume  below  145  mL
s  predictive  of  a  75%  success  rate.
Detection  of  atrial  ﬁbrosis  by  MR  angiography  as  a  pro-
nostic  marker  is  recent  and  is  not  yet  used  in  routine
ractice.  Late  phase  contrast-enhanced  acquisitions  could
dentify  zones  of  atrial  ﬁbrosis  [37],  the  substrate  of  AF,
nd  could  help  quantify  the  extent  of  the  ﬁbrosis,  which
ould  be  a  good  indicator  for  the  risk  of  post-procedural
ecurrence  [38]  as  well  as  helps  guide  the  ablation
’’ (a), with the least risk of stroke, ‘‘cactus’’ (b) or ‘‘wind sock’’
troke multiplied by 8.
d
t
c
T
T
s
[
i
w
r
r
V
R
a
s
s
t
D
P
T
n
t
bImaging  of  AF  ablation  
procedure  by  directly  targeting  the  areas  of  ﬁbrosis  that
cause  the  development  of  chronic  AF.  T1-mapping  MR
sequences  could  provide  similar  information  [39].
Finally,  the  morphology  of  the  LAA  is  a  factor  that
could  help  stratify  the  risk  of  embolism  in  patients  with
AF  [40].  The  risk  of  stroke  is  therefore  lower  in  a  ‘‘chicken
wing’’  morphology  than  in  other  morphologies,  while  the
risk  of  stroke  in  a  ‘‘cactus’’  or  a  ‘‘windsock’’  morphology
is  four  times  greater  and  up  to  eight  times  greater  in  a
‘‘cauliﬂower’’  morphology  (Fig.  14)  [41].
Post-procedural follow-up
Catheter  ablation  of  AF  is  a  long,  complex,  and  thus  risky
procedure.  Registers  describe  severe  complications  in  up
to  6%  of  patients,  although  mortalities  are  rare,  less  than
1/2000  [7].  There  are  early  complications  that  develop
immediately  or  within  24  hours  after  the  procedure,  and
that  are  due  to  either  direct  thermal  injury,  or  thromboem-
bolic  or  hemorrhagic  events,  and  late  complications  that
occur  more  than  one  week  after  the  procedure  and  are  sec-
ondary  to  thermal  overload  to  the  extracardiac  structures
[42].  Imaging  plays  an  important  role  in  the  diagnosis  of  both
these  types  of  complications.
Early complicationsCardiac tamponade
This  is  the  most  common  and  also  the  most  dangerous
complication,  and  is  found  in  1  to  3%  of  procedures  [16,43].
It  occurs  either  during  transseptal  puncture  or  ablation.  It  is
t
c
a
Figure 15. A 29-year-old man with paroxysmal AF. Moderate stenosis 
superior PV viewed with 3D VR reconstruction (a) and axial images (b), di
Pre-procedural scan of the initial ablation procedure (c) is used as a com1121
iagnosed  in  the  operating  room  by  echocardiography,  and
reatment  is  generally  performed  by  transcutaneous  peri-
ardiac  puncture.  The  need  for  surgery  is  rare.
hromboembolic complications
hey  occur  in  0  to  5%  of  the  cases,  and  include  tran-
ient  ischemic  attack  or  ischemic  stroke  and  gas  embolisms
16,43]  that  are  often  infraclinical.  Systematic  MRI  stud-
es  have  shown  that  asymptomatic  cerebral  microembolisms
ere  very  frequent:  up  to  17%  of  patients  had  foci  with
estricted  diffusion  24—48  h  after  the  procedure  [44],  which
egress  at  the  3-month  follow-up  study.
ascular and hemorrhagic complications
eported  in  0  to  10%  of  procedures,  these  complications
re  mainly  due  to  the  femoral  vein  approach  and  the
trong  peri-procedural  anticoagulation.  Femoral  puncture
ite  hematomas  are  fairly  frequent,  while  arteriovenous  ﬁs-
ula  and  pseudoaneurysms  are  rarer  [45].
elayed complications
ulmonary vein stenosis
hese  were  the  most  frequent  complications  when  the  tech-
ique  was  ﬁrst  performed  and  were  described  in  up  to  2%  of
he  procedures  [43]. Once  circumferential  isolation  began
eing  performed  by  wide  encircling  of  the  outside  area  of
he  ostia,  it  has  become  rare.
It  is  the  cause  of  non-speciﬁc  clinical  symptoms  including
ough,  dyspnea,  chest  pain  and  even  hemoptysis.  Moder-
te  stenosis  (<50%)  of  several  PV  or  tight  stenosis  (>70%)
(55% reduction in diameter, 70% reduction in surface) of the right
scovered during the evaluation for a second AF ablation procedure.
parative reference.
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f  a  single  or  even  two  contralateral  PV  can  remain  totally
symptomatic  [42].
Based  on  these  clinical  signs,  the  diagnosis  is  conﬁrmed
n  imaging  [46].  The  gold  standard  is  MDCT  angiography
Fig.  15).  MR  angiography  is  an  effective  alternative.  V/Q
cintigraphy  can  suggest  the  diagnosis  by  identifying  a  per-
usion  defect  in  a  normally  ventilated  zone.  Signiﬁcant
tenosis  is  then  deﬁned  as  a  reduction  in  the  surface  of  the
umen  of  more  than  70%.  Very  tight  stenosis  can  sometimes
esult  in  PV  thrombosis.  Comparison  with  pre-operative
mages  is  useful  in  these  cases.
Systematic  post-procedural  screening  by  imaging  is  not
ecommended,  except  for  patients  who  must  undergo
nother  ablation  procedure.  Treatment,  which  is  rarely  nec-
ssary,  involves  angioplasty  with  stenting  when  needed.
trial-esophageal ﬁstula
his  is  a  rare  but  severe  complication  that  involves  0.1  to
.25%  of  the  procedures,  with  nearly  80%  mortality  [16]. It  is
econdary  to  thermal  ulceration  or  atrial  perforation.  Peri-
rocedural  prevention  includes  monitoring  the  esophagus  in
edated  patients  by  a  thermal  probe.  The  use  of  cryoablation
nstead  of  radiofrequency  may  reduce  this  complication  [5].
Symptoms  develop  two  to  four  weeks  after  the  procedure
nd  associate  fever,  septic  embolisms  (especially  cerebral)
nd  even  septic  shock.
The  positive  diagnosis  is  made  by  chest  MDCT,  ideally  with
ontrast  medium  administration  and  additional  acquisitions
f  the  abdomen,  pelvis  and  brain:  peri-esophageal  inﬁltra-
ion,  ﬁstula  between  the  anterior  esophageal  wall  and  the
osterior  LA  wall,  mediastinal  or  LA  gas,  mediastinal  ﬂuid
ollection  and  distant  abscesses  are  the  MDCT  signs  con-
rming  the  clinical  suspicion.  Emergency  treatment  includes
urgical  repair  or  endoscopic  esophageal  stent  placement.
erve injury
erve  injury  occurs  in  approximately  1%  of  procedures  [42].
njury  to  the  vagal  nerve  can  cause  pyloric  spasms  and
astric  discomfort,  which  regresses  spontaneously  in  less
han  12  months.  Injury  to  the  phrenic  nerve  causes  paralysis
f  the  diaphragm,  which  is  usually  asymptomatic  but  may
ause  dyspnea,  hiccups  or  coughing.  It  generally  completely
esolves  in  less  than  six  months.
onclusion
ross-sectional  imaging,  in  particular  pre-procedural  MDCT
ngiography  of  the  PV,  is  valuable  for  the  planning  of
atheter  ablation  of  AF  by  providing  comprehensive  informa-
ion  on  the  anatomy  of  the  PV  and  detecting  patients  at  risk,
s  well  for  guiding  the  procedure  by  fusion  with  the  mapping
ystem.  Anatomical  variations  of  the  PV  are  frequent  with  a
upernumerary  right  PV  in  20%  of  the  cases  (mainly  the  mid-
le  PV)  and  a  single  common  left  ostium  in  10%.  Imaging  has prognostic  value,  with  a  high  risk  of  recurrence  when  LA
olume  is  above  145  mL.  Finally,  and  although  they  are  rare,
he  diagnosis  of  potentially  life-threatening  complications
uch  as  atrial-esophageal  ﬁstula  relies  on  imaging.
[M.  Ohana  et  al.
isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
[1] Haissaguerre M, Gencel L, Fischer B, Metayer P, Poquet F, Mar-
cus FI, et al. Successful catheter ablation of atrial ﬁbrillation.
J Cardiovasc Electrophysiol 1994;5:1045—52.
[2] Kautzner J, Peichl P. The role of imaging to support catheter
ablation of atrial ﬁbrillation. Cor et Vasa 2012;54:e375—85.
[3] Davy JM, Roubille F, Tri Cung T, Massin F, Crausac F, Raczka F,
et al. Atrial ﬁbrillation in 2010: an increasing morbidity and
mortality burden. Ann Cardiol Angeiol 2010;59:S4—13.
[4] European Heart Rhythm Association, European Association
for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GYH,
Schotten U, et al. Guidelines for the management of atrial
ﬁbrillation: the task force for the management of atrial ﬁbril-
lation of the European Society of Cardiology (ESC). Eur Heart J
2010;31:2369—429.
[5] Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D,
Hohnloser SH, et al. 2012 focused update of the ESC guide-
lines for the management of atrial ﬁbrillation. Eur Heart J
2012;33:2719—47.
[6] Davy JM, Tri Cung T, Cransac F, Massin F, Tapiero A, Roubille
F, et al. Permanent atrial ﬁbrillation. Arch Cardiovasc Dis
2011;3:225—35.
[7] Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen
SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement
on catheter and surgical ablation of atrial ﬁbrillation: rec-
ommendations for patient selection, procedural techniques,
patient management and follow-up, deﬁnitions, endpoints and
research trial design. Europace 2012;14:528—606.
[8] Sueda T, Nagata H, Orihashi K, Morita S, Okada K, Sueshiro
M, et al. Efﬁcacy of a simple left atrial procedure for chronic
atrial ﬁbrillation in mitral valve operations. Ann Thorac Surg
1997;63:1070—5.
[9] Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D,
Lazzara R, et al. Catheter ablation of cardiac autonomic
nerves for prevention of vagal atrial ﬁbrillation. Circulation
2000;102:2774—80.
10] Hwang C, Wu TJ, Doshi RN, Peter CT, Chen PS. Vein of marshall
cannulation for the analysis of electrical activity in patients
with focal atrial ﬁbrillation. Circulation 2000;101:1503—5.
11] Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable
microreentrant sources as a mechanism of atrial ﬁbrillation in
the isolated sheep heart. Circulation 2000;101:194—9.
12] Narayan SM, Shivkumar K, Krummen DE, Miller JM, Rappel WJ.
Panoramic electrophysiological mapping but not electrogram
morphology identiﬁes stable sources for human atrial ﬁbrilla-
tion: stable atrial ﬁbrillation rotors and focal sources relate
poorly to fractionated electrograms. Circ Arrhythm Electro-
physiol 2013;6:58—67.
13] Haissaguerre M, Hocini M, Shah AJ, Derval N, Sacher F, Jais
P, et al. Noninvasive panoramic mapping of human atrial
ﬁbrillation mechanisms: a feasibility report. J Cardiovasc Elec-
trophysiol 2013;24:711—7.
14] Ching CK, Patel D, Natale A. Catheter ablation of atrial ﬁbril-
lation. J Arrhythm 2007;23:85—101.
15] Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsanee-
witayakul B, Vasavakul T, et al. A new approach for catheter
ablation of atrial ﬁbrillation: mapping of the electrophysiologic
substrate. J Am Coll Cardiol 2004;43:2044—53.
16] Cappato R, Calkins H, Chen SA, Davies W, Lesaka Y, Kalman J,
et al. Updated worldwide survey on the methods, efﬁcacy, and
[[
[
[
[
[
[
[
[
[
[
[
[Imaging  of  AF  ablation  
safety of catheter ablation for human atrial ﬁbrillation. Circ
Arrhythm Electrophysiol 2010;3:32—8.
[17] Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS,
et al. Long-term outcomes of catheter ablation of atrial ﬁbrilla-
tion: a systematic review and meta-analysis. J Am Heart Assoc
2013;2:e004549.
[18] Derval N, Sacher F, Deplagne A, Hocini M, Bordachar P, Ritter P,
et al. Radiofrequency ablation of atrial ﬁbrillation. Ann Cardiol
Angeiol 2009;58:S50—4.
[19] Tse HF, Reek S, Timmermans C, Lee KLF, Geller JC, Rodriguez
LM, et al. Pulmonary vein isolation using transvenous catheter
cryoablation for treatment of atrial ﬁbrillation without risk of
pulmonary vein stenosis. J Am Coll Cardiol 2003;42:752—8.
[20] Ozcan C, Ruskin J, Mansour M. Cryoballoon catheter ablation
in atrial ﬁbrillation. Cardiol Res Pract 2011;2011:1—6.
[21] Thorning C, Hamady M, Liaw JV, Juli C, Lim PB, Dhawan R,
et al. CT evaluation of pulmonary venous anatomy variation
in patients undergoing catheter ablation for atrial ﬁbrillation.
Clin Imaging 2011;35:1—9.
[22] Chu ZG, Gao HL, Yang ZG, Yu JQ, Deng W, Wang QL, et al. Pul-
monary veins of the patients with atrial ﬁbrillation: dual-source
computed tomography evaluation prior to radiofrequency
catheter ablation. Int J Cardiol 2011;148:245—8.
[23] Lacomis JM, Wigginton W, Fuhrman C, Schwartzman D, Armﬁeld
DR, Pealer KM. Multi-detector row CT of the left atrium and
pulmonary veins before radio-frequency catheter ablation for
atrial ﬁbrillation. Radiographics 2003;23:S35—48.
[24] Hur J, Kim YJ, Lee HJ, Ha JW, Heo JH, Choi EY, et al.
Left atrial appendage thrombi in stroke patients: detection
with two-phase cardiac CT angiography versus transesophageal
echocardiography. Radiology 2009;251:683—90.
[25] Ohana M, Jeung MY, Labani A, El Ghannudi S, Roy C. Thoracic
dual energy CT: acquisition protocols, current applications and
future developments. Diagn Interv Imaging 2014;95:1017—26.
[26] Hur J, Kim YJ, Lee H-J, Nam JE, Hong YJ, Kim HY, et al. Car-
dioembolic stroke: dual-energy cardiac CT for differentiation
of left atrial appendage thrombus and circulatory stasis. Radi-
ology 2012;263:688—95.
[27] Martinez MW, Kirsch J, Williamson EE, Syed IS, Feng D, Ommen
S, et al. Utility of nongated multidetector computed tomogra-
phy for detection of left atrial thrombus in patients undergoing
catheter ablation of atrial ﬁbrillation. JACC Cardiovasc Imaging
2009;2:69—76.
[28] Sohns C, Sohns JM, Vollmann D, Lüthje L, Bergau L, Dorenkamp
M, et al. Left atrial volumetry from routine diagnostic work up
prior to pulmonary vein ablation is a good predictor of free-
dom from atrial ﬁbrillation. Eur Heart J Cardiovasc Imaging
2013;14:684—91.
[29] Koka AR, Yau J, Van Why C, Cohen IS, Halpern EJ. Under-
estimation of left atrial size measured with transthoracic
echocardiography compared with 3D MDCT. Am J Roentgenol
2010;194:W375—81.
[30] Abecasis J, Dourado R, Ferreira A, Saraiva C, Cavaco D, San-
tos KR, et al. Left atrial volume calculated by multi-detector
computed tomography may predict successful pulmonary vein
isolation in catheter ablation of atrial ﬁbrillation. Europace
2009;11:1289—94.
[31] Sohns C, Sossalla S, Vollmann D, Luethje L, Seegers J, Schmitto
J, et al. Extra cardiac ﬁndings by 64-multidetector computed
tomography in patients with symptomatic atrial ﬁbrillation
prior to pulmonal vein isolation. Int J Cardiovasc Imaging
2011;27:127—34.
[32] Casella M, Perna F, Pontone G, Dello Russo A, Andreini D,
Pelargonio G, et al. Prevalence and clinical signiﬁcance of
[1123
collateral ﬁndings detected by chest computed tomography
in patients undergoing atrial ﬁbrillation ablation. Europace
2012;14:209—16.
33] Groarke JD, Waller AH, Vita TS, Michaud GF, Di Carli MF,
Blankstein R, et al. Feasibility study of electrocardiographic
and respiratory gated, gadolinium enhanced magnetic reso-
nance angiography of pulmonary veins and the impact of heart
rate and rhythm on study quality. J Cardiovasc Magn Reson
2014;16:43.
34] Rathi VK, Reddy ST, Anreddy S, Belden W,  Yamrozik JA, Williams
RB, et al. Contrast-enhanced cmr is equally effective as tee in
the evaluation of left atrial appendage thrombus in patients
with atrial ﬁbrillation undergoing pulmonary vein isolation pro-
cedure. Heart Rhythm 2013;10:1021—7.
35] den Uijl DW, Bax JJ. Left atrial size as a predictor of suc-
cessful radiofrequency catheter ablation for atrial ﬁbrillation.
Europace 2009;11:1255—6.
36] von Bary C, Dornia C, Eissnert C, Nedios S, Roser M, Hamer O,
et al. Predictive value of left atrial volume measured by non-
invasive cardiac imaging in the treatment of paroxysmal atrial
ﬁbrillation. J Interv Card Electrophysiol 2012;34:181—8.
37] Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS,
Fish EN, et al. Detection and quantiﬁcation of left atrial
structural remodeling with delayed-enhancement magnetic
resonance imaging in patients with atrial ﬁbrillation. Circula-
tion 2009;119:1758—67.
38] McGann C, Kholmovski E, Blauer J, Vijayakumar S, Haslam
T, Cates J, et al. Dark regions of no-reﬂow on late gadolin-
ium enhancement magnetic resonance imaging result in scar
formation after atrial ﬁbrillation ablation. J Am Coll Cardiol
2011;58:177—85.
39] Beinart R, Khurram IM, Liu S, Yarmohammadi H, Halperin HR,
Bluemke DA, et al. Cardiac magnetic resonance T1 mapping of
left atrial myocardium. Heart Rhythm 2013;10:1325—31.
40] Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T,
Nishiyama N, et al. Anatomical characteristics of the left atrial
appendage in cardiogenic stroke with low chads2 scores. Heart
Rhythm 2013;10:921—5.
41] Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I,
Gili S, et al. Does the left atrial appendage morphology corre-
late with the risk of stroke in patients with atrial ﬁbrillation?
Results from a multicenter study. J Am Coll Cardiol 2012;60:
531—8.
42] Doppalapudi H, Yamada T, Kay GN. Complications during
catheter ablation of atrial ﬁbrillation: identiﬁcation and pre-
vention. Heart Rhythm 2009;6:S18—25.
43] Cappato R, Calkins H, Chen SA, Davies W,  Lesaka Y, Kalman J,
et al. Worldwide survey on the methods, efﬁcacy, and safety
of catheter ablation for human atrial ﬁbrillation. Circulation
2005;111:1100—5.
44] Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E,
Cesarani F, et al. Radiofrequency catheter ablation of atrial
ﬁbrillation: a cause of silent thromboembolism? Magnetic res-
onance imaging assessment of cerebral thromboembolism in
patients undergoing ablation of atrial ﬁbrillation. Circulation
2010;122:1667—73.
45] Natale A, Raviele A, Arentz T, Calkins H, Chen SA, Haissa-
guerre M, et al. Venice chart international consensus document
on atrial ﬁbrillation ablation. J Cardiovasc Electrophysiol
2007;18:560—80.46] Ghaye B, Szapiro D, Dacher JN, Rodriguez LM, Timmermans
C, Devillers D, et al. Percutaneous ablation for atrial ﬁbril-
lation: the role of cross-sectional imaging. Radiographics
2003;23:S19—33.
